A new study suggests that the long-term antidepressant effects of psychedelics may be driven by persistent changes in how ...

Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...

In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...

Two-thirds of participants in a small-scale clinical trial said they were in complete remission from depression five years later Interviews suggest the treatment helped patients see their depression ...

A landmark study challenges conventional wisdom about depression treatment, revealing that psilocybin therapy may match or exceed the effectiveness of traditional antidepressants. This research ...

Psilocybin has captured attention for its potential to ease depression and anxiety. But new findings from the University of California (UC), Davis, caution that psilocybin may not be a ...

LONDON — The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest trial of its type ever conducted. Psilocybin was ...

A single dose of psilocybin significantly decreased depression and anxiety in people with cancer, according to a new study. Psilocybin is a chemical in certain mushrooms that causes hallucinogenic ...

Researchers have developed a new model to study the antidepressant and anti-anxiety effects of psilocybin in mice.